These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 16728647

  • 1. Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine.
    Marks MJ, Whiteaker P, Collins AC.
    Mol Pharmacol; 2006 Sep; 70(3):947-59. PubMed ID: 16728647
    [Abstract] [Full Text] [Related]

  • 2. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
    Marks MJ, Meinerz NM, Drago J, Collins AC.
    Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE, Loetz EC, Marks MJ.
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [Abstract] [Full Text] [Related]

  • 4. Nicotinic-agonist stimulated (86)Rb(+) efflux and [(3)H]epibatidine binding of mice differing in beta2 genotype.
    Marks MJ, Stitzel JA, Grady SR, Picciotto MR, Changeux JP, Collins AC.
    Neuropharmacology; 2000 Oct; 39(13):2632-45. PubMed ID: 11044733
    [Abstract] [Full Text] [Related]

  • 5. Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine.
    Whiteaker P, Jimenez M, McIntosh JM, Collins AC, Marks MJ.
    Br J Pharmacol; 2000 Oct; 131(4):729-39. PubMed ID: 11030722
    [Abstract] [Full Text] [Related]

  • 6. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta.
    Han ZY, Zoli M, Cardona A, Bourgeois JP, Changeux JP, Le Novère N.
    J Comp Neurol; 2003 Jun 16; 461(1):49-60. PubMed ID: 12722104
    [Abstract] [Full Text] [Related]

  • 7. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L, Matteoni C, Di Angelantonio S, Nistri A, Gaimarri A, Sparatore F, Canu-Boido C, Clementi F, Gotti C.
    Br J Pharmacol; 2005 Dec 16; 146(8):1096-109. PubMed ID: 16273122
    [Abstract] [Full Text] [Related]

  • 8. Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice.
    Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC.
    J Neurochem; 2002 Jun 16; 81(5):1102-15. PubMed ID: 12065623
    [Abstract] [Full Text] [Related]

  • 9. In vivo effects of 3-iodocytisine: pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites.
    Zambrano CA, Marks MJ, Cassels BK, Maccioni RB.
    Neuropharmacology; 2009 Sep 16; 57(3):332-42. PubMed ID: 19481555
    [Abstract] [Full Text] [Related]

  • 10. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
    Peng JH, Fryer JD, Hurst RS, Schroeder KM, George AA, Morrissy S, Groppi VE, Leonard SS, Lukas RJ.
    J Pharmacol Exp Ther; 2005 Apr 16; 313(1):24-35. PubMed ID: 15590768
    [Abstract] [Full Text] [Related]

  • 11. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W, Gillberg PG, Nordberg A.
    Neuroscience; 1998 Aug 16; 85(4):1121-33. PubMed ID: 9681951
    [Abstract] [Full Text] [Related]

  • 12. John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes.
    Marks MJ, Laverty DS, Whiteaker P, Salminen O, Grady SR, McIntosh JM, Collins AC.
    J Mol Neurosci; 2010 Jan 16; 40(1-2):96-104. PubMed ID: 19672723
    [Abstract] [Full Text] [Related]

  • 13. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
    Metaxas A, Al-Hasani R, Farshim P, Tubby K, Berwick A, Ledent C, Hourani S, Kitchen I, Bailey A.
    Neuropharmacology; 2013 Aug 16; 71():228-36. PubMed ID: 23583933
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and null mutation approaches reveal nicotinic receptor diversity.
    Whiteaker P, Marks MJ, Grady SR, Lu Y, Picciotto MR, Changeux JP, Collins AC.
    Eur J Pharmacol; 2000 Mar 30; 393(1-3):123-35. PubMed ID: 10771005
    [Abstract] [Full Text] [Related]

  • 15. Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain.
    Marks MJ, Smith KW, Collins AC.
    J Pharmacol Exp Ther; 1998 Apr 30; 285(1):377-86. PubMed ID: 9536034
    [Abstract] [Full Text] [Related]

  • 16. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ, Beck A, Luetje CW.
    Mol Pharmacol; 1998 Dec 30; 54(6):1132-9. PubMed ID: 9855644
    [Abstract] [Full Text] [Related]

  • 17. Postnatal upregulation of alpha4 and alpha3 nicotinic receptor subunits in the brain of alpha7 nicotinic receptor-deficient mice.
    Yu WF, Guan ZZ, Nordberg A.
    Neuroscience; 2007 Jun 08; 146(4):1618-28. PubMed ID: 17434683
    [Abstract] [Full Text] [Related]

  • 18. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration.
    Flores CM, Dávila-García MI, Ulrich YM, Kellar KJ.
    J Neurochem; 1997 Nov 08; 69(5):2216-9. PubMed ID: 9349569
    [Abstract] [Full Text] [Related]

  • 19. Nitrogen substitution modifies the activity of cytisine on neuronal nicotinic receptor subtypes.
    Carbonnelle E, Sparatore F, Canu-Boido C, Salvagno C, Baldani-Guerra B, Terstappen G, Zwart R, Vijverberg H, Clementi F, Gotti C.
    Eur J Pharmacol; 2003 Jun 20; 471(2):85-96. PubMed ID: 12818695
    [Abstract] [Full Text] [Related]

  • 20. Differential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cells.
    Ridley DL, Rogers A, Wonnacott S.
    Br J Pharmacol; 2001 Aug 20; 133(8):1286-95. PubMed ID: 11498514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.